MedTrace Logo

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

NCT03037671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-08-19

No results posted yet for this study

Summary

This study is designed to determine feasibility of using a continuous glucose monitor in pediatric, adolescent and young adult hematopoietic stem cell transplant (HSCT) recipients, and to identify the incidence and risk factors for malglycemia in primary admission for pediatric, adolescent and young adult HSCT patients as well as to characterize the relationship between outcomes and malglycemia in this population.

Conditions

  • Hematopoietic Stem Cell Transplantation

Interventions

DEVICE

Continuous Glucose Monitor (CGM)

Participants will wear the continuous glucose monitor (GCM) device during the peri-HSCT period for the duration of their initial hospital admission. No intervention based on results.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Jenna M Demedis, MD · Children's Hospital Colorado

Eligibility

Min Age
2 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-09
Primary Completion
2020-01-17
Completion
2024-04-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037671 on ClinicalTrials.gov